Eating Disorders: Types, Warning Signs, and Treatment

Eating disorders are serious, sometimes fatal mental health conditions that disrupt eating behaviors, body image, and physical health simultaneously. This page covers the major diagnostic categories, the physical and behavioral warning signs that often precede a diagnosis, and the evidence-based treatment approaches used across clinical settings. Because eating disorders carry the highest mortality rate of any psychiatric illness — a figure documented by the National Eating Disorders Association and confirmed in peer-reviewed literature — early recognition matters in a way that is difficult to overstate.

Definition and scope

Anorexia nervosa has a crude mortality rate of approximately 5.9% per decade of illness, according to a meta-analysis published in Archives of General Psychiatry — a number that makes it one of the deadliest conditions in all of psychiatry, not just in the eating disorder category. That figure tends to reframe the conversation immediately. These are not lifestyle choices or phases. They are diagnosable disorders verified in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), with specific clinical criteria that distinguish them from ordinary dieting, food preferences, or weight concerns.

The DSM-5 recognizes eight feeding and eating disorder categories. The three most clinically prevalent are anorexia nervosa, bulimia nervosa, and binge eating disorder (BED). Avoidant/restrictive food intake disorder (ARFID) — once considered primarily a childhood condition — is now understood to affect adults as well. Estimates from the National Institute of Mental Health suggest that approximately 28.8 million Americans will meet criteria for an eating disorder at some point in their lives.

Eating disorders sit at the intersection of psychiatric, psychological, and medical care, which is why they appear frequently in discussions of mental health conditions that require coordinated, multi-disciplinary treatment teams rather than a single provider.

How it works

The mechanisms driving eating disorders involve a tangle of genetic vulnerability, neurobiological factors, and environmental triggers. Neuroimaging research has identified dysregulation in dopamine and serotonin pathways — the same systems implicated in depression and mood disorders and obsessive-compulsive disorder, which frequently co-occur with eating disorders.

The three primary diagnoses differ in their core behavioral signatures:

1. Anorexia nervosa — Characterized by severe restriction of caloric intake, intense fear of weight gain, and a distorted perception of one's own body weight or shape. Two subtypes exist: restricting type and binge-purge type. Medical complications include bradycardia, electrolyte imbalance, bone density loss, and amenorrhea.

2. Bulimia nervosa — Defined by recurrent cycles of binge eating (consuming an objectively large amount of food in a discrete time period) followed by compensatory behaviors: self-induced vomiting, laxative use, fasting, or excessive exercise. Individuals with bulimia are often at a typical body weight, which delays recognition by both clinicians and family members.

3. Binge eating disorder (BED) — The most prevalent eating disorder in the United States, per the National Eating Disorders Association. It involves recurrent episodes of binge eating without the compensatory behaviors seen in bulimia. Marked distress, shame, and a sense of loss of control are central features.

ARFID, by contrast, involves restriction not driven by body image concerns but by sensory sensitivity, fear of choking or vomiting, or low interest in food — a distinction that changes the treatment approach substantially.

Common scenarios

Eating disorders present differently depending on age, gender, and the specific diagnosis involved. Adolescents with anorexia may exhibit sudden food restriction framed as "healthy eating," withdrawal from social meals, and excessive exercise rituals that appear on the surface like discipline. The overlap with mental health in children and adolescents is significant — onset of anorexia peaks between ages 15 and 19.

Adults with BED may report decades of cyclical dieting, episodes of eating rapidly and alone, and significant shame that prevents them from disclosing the behavior to a physician. Because BED does not produce the visible physical changes associated with anorexia, it is routinely underdiagnosed.

Men and boys represent approximately 1 in 3 individuals with binge eating disorder, according to the National Eating Disorders Association, yet remain underrepresented in treatment — a gap attributed partly to stigma and partly to screening tools historically calibrated toward female presentation. That stigma problem has a dedicated framework worth examining at mental health stigma.

Bulimia's warning signs are often physical rather than behavioral at first glance: dental enamel erosion from repeated vomiting, swollen salivary glands, calluses on the knuckles (Russell's sign), and unexplained electrolyte abnormalities flagged in routine bloodwork.

Decision boundaries

Distinguishing eating disorders from each other — and from subclinical disordered eating — requires clinical assessment, not a checklist. A few decision boundaries guide that assessment:

• Anorexia vs. bulimia — Body weight is not a reliable differentiator since the binge-purge subtype of anorexia and bulimia can look similar behaviorally. The defining axis is whether the individual meets the low-weight threshold (Body Mass Index under 17.5 in adults, or failure to achieve expected weight in adolescents) combined with the cognitive distortion around weight and shape.
• Bulimia vs. BED — The presence or absence of compensatory behavior is the single clinical dividing line. Binge episodes alone do not constitute bulimia.
• ARFID vs. anorexia — Both involve restriction, but anorexia is anchored in weight and shape preoccupation. ARFID is not.

Treatment selection follows the diagnosis. Cognitive behavioral therapy is the most evidence-supported psychotherapy for bulimia and BED. Anorexia typically requires weight restoration before outpatient psychotherapy becomes effective — a sequencing problem that often means the decision between inpatient vs. outpatient mental health care must be resolved before any other treatment planning begins. Medication plays a more limited role; fluoxetine (Prozac) holds FDA approval specifically for bulimia nervosa, making it one of the few psychiatric medications approved for a specific eating disorder. For anyone trying to identify the right level of support, how to get help for mental health outlines the pathways from initial screening through specialty referral.